Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

New NLRP3 agonists identified at Sichuan Kelun-Biotech Biopharmaceutical

April 15, 2021

LY-3484356 shows efficacy in ESR1 wild-type and mutant xenografts

April 15, 2021

Iterion completes enrollment in phase I/IIa dose-expansion study of tegavivint in desmoid tumors

April 14, 2021

Merck & Co. discovers KRAS G12C mutant inhibitors

April 14, 2021

Accutar Biotechnology synthesizes new androgen receptor degrading PROTACs

April 14, 2021

New PARG inhibitors identified at Ideaya Biosciences

April 14, 2021

First-in-class pan-inhibitor of KDM4 TACH-101 active in multiple cancer models

April 14, 2021

CFT-7455 shows potent tumor regression in IMiD-resistant multiple myeloma xenografts

April 14, 2021

AZD-5305 shows excellent efficacy in BRCA-mutant xenografts

April 13, 2021

PC-14586 leads to robust tumor regression in NUGC3 xenografts

April 13, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026